Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:FPRX
Date9/2013
Raised
Post IPO Valuation

General Information

Websitefiveprime.com
CategoryBioTech
Phone415-365-5600
Emailbusiness.developm...
Employees
Founded2002
DescriptionOncology therapy

Offices

San Francisco, USA
1650 Owens Street
Suite 200
San Francisco, CA, 94158-2216
USA

People

Founder, Chairman and CEO, Board of Directors
President and CEO
Senior VP, Chief Medical Officer
Vice President, Preclinical Development
Vice President, Human Resources
Vice President, Biology
Board of Directors
Board of Directors
Show All People

Funding

TOTAL $146M
FUNDING TOTAL $62.5M
Venture Round, 2/2005
Domain Associates
HealthCap
J.P. Morgan Securities Inc.
Kleiner Perkins Caufield & Byers
Versant Ventures
Texas Pacific Group
Advanced Technology Ventures
Wellcome Trust
Diamond Capital Company
Singapore Bio-Innovations
$45M
Venture Round, 5/2008
Pfizer Venture Investments
Venture Round, 9/2010
$7.5M
Private Equity, 4/2012
Versant Ventures
Kleiner Perkins Caufield & Byers
$10M
POST IPO FUNDING TOTAL $83M
Post IPO Equity, 9/2013
$62M
Post IPO Equity, 3/2014
$21M

Tags

Five Prime Therapeutics

FivePrime is a privately held protein therapeutics discovery and development company located in San Francisco’s Mission Bay. Its proprietary discovery platform allows the rapid screening of the complete set of secreted proteins and their receptors in medically relevant, cell-based assays to identify new biotherapeutics. FivePrime is applying its high throughput biologics discovery system first in the areas of oncology, metabolic disease, immunology and regenerative medicine with lead proteins in pre-clinical development to treat cancer and type II diabetes

Recent Milestones

Videos

Screenshots

Five Prime Therapeutics screenshot
Above: Homepage
Uploaded: 5/27/09

Stock Price

Sources

  1. Five Prime Therapeutics, Inc. Raises $45MM in Private Financing (fiveprime.com) [edit]
  2. Capital Funding Report [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
  5. Five Prime Therapeutics IPO Raises $62M (burrillreport.com) [edit]
  6. SEC (sec.gov) [edit]
Edit This Page
Last Edited 3/31/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy